High risk groups are still not being vaccinated

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7484.198-a (Published 20 January 2005) Cite this as: BMJ 2005;330:198

Authors' reply

  1. Rakesh Aggarwal, additional professor ([email protected]),
  2. Piyush Ranjan, senior research associate
  1. Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India

    EDITOR—We agree with Mansoor and Wilson that hepatitis B vaccine has considerable efficacy even when the recommended schedule is not strictly adhered to. Two doses are possibly as effective …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial